APO Research
Talk to an analyst

APO RESEARCH · REPORT

Decongestant

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Decongestant Market Outlook and Growth Opportunities 2026

31 December 2025193 pages

Choose your research edition.

Industry ResearchDecongestant Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Decongestant Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Decongestant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Decongestant Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Decongestant Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Decongestant market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Decongestant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Decongestant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Decongestant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Decongestant market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Decongestant market include Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Ranbaxy Laboratories Ltd., Cipla Ltd. and Beximco Pharmaceuticals Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Decongestant market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Decongestant and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Decongestant sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Decongestant market size, projected growth trends, production technologies, key applications, and end-use industries.

Decongestant Segment by Company

Teva Pharmaceutical Industries Ltd.

Novartis AG

Mylan N.V.

Ranbaxy Laboratories Ltd.

Cipla Ltd.

Beximco Pharmaceuticals Ltd.

Decongestant Segment by Type

Nasal Sprays

Capsules

Tablets

Decongestant Segment by Application

Research & Academic Laboratories

Hospitals

Clinic

Other

Decongestant Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Decongestant status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Decongestant market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Decongestant significant trends, drivers, influence factors in global and regions.

6. To analyze Decongestant competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Decongestant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Decongestant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Decongestant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Decongestant market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Decongestant industry.

Chapter 3: Detailed analysis of Decongestant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Decongestant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Decongestant in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Decongestant Industry Trends Table 2. Decongestant Industry Drivers Table 3. Decongestant Industry Opportunities and Challenges Table 4. Decongestant Industry Restraints Table 5. Global Decongestant Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Decongestant Revenue Share by Company (2021-2026) Table 7. Global Decongestant Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Decongestant Sales Volume Share by Company (2021-2026) Table 9. Global Decongestant Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Decongestant Company Ranking, (2024-2026) & (USD Million) Table 11. Global Decongestant Key Company Manufacturing Base & Headquarters Table 12. Global Decongestant Company, Product Type & Application Table 13. Global Decongestant Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Decongestant by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Nasal Sprays Table 18. Significant Companies of Capsules Table 19. Significant Companies of Tablets Table 20. Global Decongestant Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Decongestant Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Decongestant Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Decongestant Sales Volume Share by Type (2021-2026) Table 24. Global Decongestant Sales Volume Share by Type (2027-2032) Table 25. Global Decongestant Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Decongestant Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Decongestant Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Decongestant Sales Value Share by Type (2021-2026) Table 29. Global Decongestant Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Research & Academic Laboratories Table 31. Significant Companies of Hospitals Table 32. Significant Companies of Clinic Table 33. Significant Companies of Other Table 34. Global Decongestant Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Decongestant Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Decongestant Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Decongestant Sales Volume Share by Application (2021-2026) Table 38. Global Decongestant Sales Volume Share by Application (2027-2032) Table 39. Global Decongestant Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Decongestant Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Decongestant Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Decongestant Sales Value Share by Application (2021-2026) Table 43. Global Decongestant Sales Value Share by Application (2027-2032) Table 44. Global Decongestant Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Decongestant Sales by Region (2021-2026) & (K Units) Table 46. Global Decongestant Sales Market Share by Region (2021-2026) Table 47. Global Decongestant Sales by Region (2027-2032) & (K Units) Table 48. Global Decongestant Sales Market Share by Region (2027-2032) Table 49. Global Decongestant Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Decongestant Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Decongestant Sales Value Share by Region (2021-2026) Table 52. Global Decongestant Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Decongestant Sales Value Share by Region (2027-2032) Table 54. Global Decongestant Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Decongestant Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Decongestant Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Decongestant Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Decongestant Sales by Country (2021-2026) & (K Units) Table 59. Global Decongestant Sales Market Share by Country (2021-2026) Table 60. Global Decongestant Sales by Country (2027-2032) & (K Units) Table 61. Global Decongestant Sales Market Share by Country (2027-2032) Table 62. Global Decongestant Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Decongestant Sales Value Market Share by Country (2021-2026) Table 64. Global Decongestant Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Decongestant Sales Value Market Share by Country (2027-2032) Table 66. Teva Pharmaceutical Industries Ltd. Company Information Table 67. Teva Pharmaceutical Industries Ltd. Business Overview Table 68. Teva Pharmaceutical Industries Ltd. Decongestant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Teva Pharmaceutical Industries Ltd. Decongestant Product Portfolio Table 70. Teva Pharmaceutical Industries Ltd. Recent Development Table 71. Novartis AG Company Information Table 72. Novartis AG Business Overview Table 73. Novartis AG Decongestant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Novartis AG Decongestant Product Portfolio Table 75. Novartis AG Recent Development Table 76. Mylan N.V. Company Information Table 77. Mylan N.V. Business Overview Table 78. Mylan N.V. Decongestant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Mylan N.V. Decongestant Product Portfolio Table 80. Mylan N.V. Recent Development Table 81. Ranbaxy Laboratories Ltd. Company Information Table 82. Ranbaxy Laboratories Ltd. Business Overview Table 83. Ranbaxy Laboratories Ltd. Decongestant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Ranbaxy Laboratories Ltd. Decongestant Product Portfolio Table 85. Ranbaxy Laboratories Ltd. Recent Development Table 86. Cipla Ltd. Company Information Table 87. Cipla Ltd. Business Overview Table 88. Cipla Ltd. Decongestant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Cipla Ltd. Decongestant Product Portfolio Table 90. Cipla Ltd. Recent Development Table 91. Beximco Pharmaceuticals Ltd. Company Information Table 92. Beximco Pharmaceuticals Ltd. Business Overview Table 93. Beximco Pharmaceuticals Ltd. Decongestant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Beximco Pharmaceuticals Ltd. Decongestant Product Portfolio Table 95. Beximco Pharmaceuticals Ltd. Recent Development Table 96. Key Raw Materials Table 97. Raw Materials Key Suppliers Table 98. Decongestant Distributors List Table 99. Decongestant Customers List Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Decongestant Product Image Figure 2. Global Decongestant Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Decongestant Sales Value (2021-2032) & (US$ Million) Figure 4. Global Decongestant Sales (2021-2032) & (K Units) Figure 5. Global Decongestant Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Decongestant Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Nasal Sprays Image Figure 10. Capsules Image Figure 11. Tablets Image Figure 12. Global Decongestant Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Decongestant Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Decongestant Sales Volume Share by Type (2021-2032) Figure 15. Global Decongestant Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Decongestant Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Decongestant Sales Value Share by Type (2021-2032) Figure 18. Research & Academic Laboratories Image Figure 19. Hospitals Image Figure 20. Clinic Image Figure 21. Other Image Figure 22. Global Decongestant Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Decongestant Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Decongestant Sales Volume Share by Application (2021-2032) Figure 25. Global Decongestant Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Decongestant Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Decongestant Sales Value Share by Application (2021-2032) Figure 28. Global Decongestant Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Decongestant Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Decongestant Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Decongestant Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Decongestant Sales Value (2021-2032) & (US$ Million) Figure 33. North America Decongestant Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Decongestant Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Decongestant Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Decongestant Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Decongestant Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Decongestant Sales Value (2021-2032) & (US$ Million) Figure 39. South America Decongestant Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Decongestant Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Decongestant Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Decongestant Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Decongestant Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Sprays
  • Capsules
  • Tablets
Applications
  • Research & Academic Laboratories
  • Hospitals
  • Clinic
  • Other
Companies covered
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Mylan N.V.
  • Ranbaxy Laboratories Ltd.
  • Cipla Ltd.
  • Beximco Pharmaceuticals Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Decongestant Sales Value (2021-2032)
  4. 1.2.2 Global Decongestant Sales Volume (2021-2032)
  5. 1.2.3 Global Decongestant Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Decongestant Market Dynamics
  1. 2.1 Decongestant Industry Trends
  2. 2.2 Decongestant Industry Drivers
  3. 2.3 Decongestant Industry Opportunities and Challenges
  4. 2.4 Decongestant Industry Restraints
3 Decongestant Market by Company
  1. 3.1 Global Decongestant Company Revenue Ranking in 2025
  2. 3.2 Global Decongestant Revenue by Company (2021-2026)
  3. 3.3 Global Decongestant Sales Volume by Company (2021-2026)
  4. 3.4 Global Decongestant Average Price by Company (2021-2026)
  5. 3.5 Global Decongestant Company Ranking (2024-2026)
  6. 3.6 Global Decongestant Company Manufacturing Base and Headquarters
  7. 3.7 Global Decongestant Company Product Type and Application
  8. 3.8 Global Decongestant Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Decongestant Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Decongestant Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Decongestant Market by Type
  1. 4.1 Decongestant Type Introduction
  2. 4.1.1 Nasal Sprays
  3. 4.1.2 Capsules
  4. 4.1.3 Tablets
  5. 4.2 Global Decongestant Sales Volume by Type
  6. 4.2.1 Global Decongestant Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Decongestant Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Decongestant Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Decongestant Sales Value by Type
  10. 4.3.1 Global Decongestant Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Decongestant Sales Value by Type (2021-2032)
  12. 4.3.3 Global Decongestant Sales Value Share by Type (2021-2032)
5 Decongestant Market by Application
  1. 5.1 Decongestant Application Introduction
  2. 5.1.1 Research & Academic Laboratories
  3. 5.1.2 Hospitals
  4. 5.1.3 Clinic
  5. 5.1.4 Other
  6. 5.2 Global Decongestant Sales Volume by Application
  7. 5.2.1 Global Decongestant Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Decongestant Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Decongestant Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Decongestant Sales Value by Application
  11. 5.3.1 Global Decongestant Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Decongestant Sales Value by Application (2021-2032)
  13. 5.3.3 Global Decongestant Sales Value Share by Application (2021-2032)
6 Decongestant Regional Sales and Value Analysis
  1. 6.1 Global Decongestant Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Decongestant Sales by Region (2021-2032)
  3. 6.2.1 Global Decongestant Sales by Region: 2021-2026
  4. 6.2.2 Global Decongestant Sales by Region (2027-2032)
  5. 6.3 Global Decongestant Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Decongestant Sales Value by Region (2021-2032)
  7. 6.4.1 Global Decongestant Sales Value by Region: 2021-2026
  8. 6.4.2 Global Decongestant Sales Value by Region (2027-2032)
  9. 6.5 Global Decongestant Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Decongestant Sales Value (2021-2032)
  12. 6.6.2 North America Decongestant Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Decongestant Sales Value (2021-2032)
  15. 6.7.2 Europe Decongestant Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Decongestant Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Decongestant Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Decongestant Sales Value (2021-2032)
  21. 6.9.2 South America Decongestant Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Decongestant Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Decongestant Sales Value Share by Country, 2025 VS 2032
7 Decongestant Country-level Sales and Value Analysis
  1. 7.1 Global Decongestant Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Decongestant Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Decongestant Sales by Country (2021-2032)
  4. 7.3.1 Global Decongestant Sales by Country (2021-2026)
  5. 7.3.2 Global Decongestant Sales by Country (2027-2032)
  6. 7.4 Global Decongestant Sales Value by Country (2021-2032)
  7. 7.4.1 Global Decongestant Sales Value by Country (2021-2026)
  8. 7.4.2 Global Decongestant Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Decongestant Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Decongestant Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Decongestant Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Decongestant Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Decongestant Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Decongestant Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Decongestant Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Decongestant Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Decongestant Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Decongestant Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Decongestant Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Decongestant Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Decongestant Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Decongestant Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Decongestant Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Decongestant Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Decongestant Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Decongestant Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Decongestant Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Decongestant Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Decongestant Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Decongestant Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Decongestant Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Decongestant Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Decongestant Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Decongestant Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Decongestant Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Decongestant Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Decongestant Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Decongestant Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Decongestant Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Decongestant Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Decongestant Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Decongestant Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Decongestant Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Decongestant Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Decongestant Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Decongestant Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Decongestant Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Decongestant Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Decongestant Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Decongestant Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Decongestant Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Decongestant Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Decongestant Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Decongestant Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Decongestant Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Decongestant Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Decongestant Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Decongestant Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Decongestant Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Decongestant Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Decongestant Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Decongestant Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Decongestant Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Decongestant Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Decongestant Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Decongestant Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Decongestant Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Decongestant Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Decongestant Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Decongestant Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Decongestant Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Decongestant Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Decongestant Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Decongestant Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Decongestant Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Decongestant Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Decongestant Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Decongestant Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Decongestant Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Decongestant Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Decongestant Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Decongestant Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Decongestant Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Decongestant Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Decongestant Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Decongestant Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Decongestant Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Decongestant Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Decongestant Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Decongestant Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Decongestant Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Decongestant Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries Ltd.
  2. 8.1.1 Teva Pharmaceutical Industries Ltd. Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Ltd. Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Ltd. Decongestant Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Ltd. Decongestant Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  7. 8.2 Novartis AG
  8. 8.2.1 Novartis AG Company Information
  9. 8.2.2 Novartis AG Business Overview
  10. 8.2.3 Novartis AG Decongestant Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis AG Decongestant Product Portfolio
  12. 8.2.5 Novartis AG Recent Developments
  13. 8.3 Mylan N.V.
  14. 8.3.1 Mylan N.V. Company Information
  15. 8.3.2 Mylan N.V. Business Overview
  16. 8.3.3 Mylan N.V. Decongestant Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mylan N.V. Decongestant Product Portfolio
  18. 8.3.5 Mylan N.V. Recent Developments
  19. 8.4 Ranbaxy Laboratories Ltd.
  20. 8.4.1 Ranbaxy Laboratories Ltd. Company Information
  21. 8.4.2 Ranbaxy Laboratories Ltd. Business Overview
  22. 8.4.3 Ranbaxy Laboratories Ltd. Decongestant Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ranbaxy Laboratories Ltd. Decongestant Product Portfolio
  24. 8.4.5 Ranbaxy Laboratories Ltd. Recent Developments
  25. 8.5 Cipla Ltd.
  26. 8.5.1 Cipla Ltd. Company Information
  27. 8.5.2 Cipla Ltd. Business Overview
  28. 8.5.3 Cipla Ltd. Decongestant Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Cipla Ltd. Decongestant Product Portfolio
  30. 8.5.5 Cipla Ltd. Recent Developments
  31. 8.6 Beximco Pharmaceuticals Ltd.
  32. 8.6.1 Beximco Pharmaceuticals Ltd. Company Information
  33. 8.6.2 Beximco Pharmaceuticals Ltd. Business Overview
  34. 8.6.3 Beximco Pharmaceuticals Ltd. Decongestant Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Beximco Pharmaceuticals Ltd. Decongestant Product Portfolio
  36. 8.6.5 Beximco Pharmaceuticals Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Decongestant Value Chain Analysis
  2. 9.1.1 Decongestant Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Decongestant Sales Mode & Process
  6. 9.2 Decongestant Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Decongestant Distributors
  9. 9.2.3 Decongestant Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst